Literature DB >> 10357451

Interactions between 192-IgG saporin and intraseptal cholinergic and GABAergic drugs: role of cholinergic medial septal neurons in spatial working memory.

K C Pang1, R Nocera.   

Abstract

Rats were administered 192-IgG saporin (SAP) or vehicle into the medial septum-vertical limb of the diagonal band (MS-vDB). Starting 1 week later, the effects of intraseptal scopolamine, oxotremorine, and muscimol were tested in a T-maze alternation task. Choice accuracy in the absence of infusions did not differ between control and SAP-treated rats. Intraseptal scopolamine or muscimol impaired the choice accuracy of SAP-treated but not control rats. Oxotremorine impaired accuracy similarly in control and SAP-treated rats. The enhanced effects of scopolamine and muscimol produced by SAP are consistent with the hypothesis that cholinergic MS-vDB neurons are used in spatial working memory. The finding that SAP alone did not alter choice accuracy provides further evidence that cholinergic MS-vDB neurons are not necessary for spatial working memory. Thus, cholinergic MS-vDB neurons are involved in but not necessary for spatial working memory.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10357451     DOI: 10.1037//0735-7044.113.2.265

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  19 in total

Review 1.  The role of acetylcholine in learning and memory.

Authors:  Michael E Hasselmo
Journal:  Curr Opin Neurobiol       Date:  2006-09-29       Impact factor: 6.627

2.  Noncholinergic lesions of the medial septum impair sequential learning of different spatial locations.

Authors:  Trisha A Dwyer; Richard J Servatius; Kevin C H Pang
Journal:  J Neurosci       Date:  2007-01-10       Impact factor: 6.167

3.  Avoidance perseveration during extinction training in Wistar-Kyoto rats: an interaction of innate vulnerability and stressor intensity.

Authors:  Xilu Jiao; Kevin C H Pang; Kevin D Beck; Thomas R Minor; Richard J Servatius
Journal:  Behav Brain Res       Date:  2011-03-02       Impact factor: 3.332

4.  Increasing acetylcholine levels in the hippocampus or entorhinal cortex reverses the impairing effects of septal GABA receptor activation on spontaneous alternation.

Authors:  A Degroot; M B Parent
Journal:  Learn Mem       Date:  2000 Sep-Oct       Impact factor: 2.460

5.  Differential effects of systemic and intraseptal administration of the acetylcholinesterase inhibitor tacrine on the recovery of spatial behavior in an animal model of diencephalic amnesia.

Authors:  Jessica J Roland; Michelle Levinson; Ryan P Vetreno; Lisa M Savage
Journal:  Eur J Pharmacol       Date:  2009-12-16       Impact factor: 4.432

6.  Increasing hippocampal acetylcholine levels enhance behavioral performance in an animal model of diencephalic amnesia.

Authors:  Jessica J Roland; Katherine Mark; Ryan P Vetreno; Lisa M Savage
Journal:  Brain Res       Date:  2008-08-05       Impact factor: 3.252

Review 7.  Potential roles of cholinergic modulation in the neural coding of location and movement speed.

Authors:  Holger Dannenberg; James R Hinman; Michael E Hasselmo
Journal:  J Physiol Paris       Date:  2016-09-24

8.  Hippocampal infusions of glucose reverse memory deficits produced by co-infusions of a GABA receptor agonist.

Authors:  Desiree L Krebs-Kraft; Marise B Parent
Journal:  Neurobiol Learn Mem       Date:  2007-08-28       Impact factor: 2.877

9.  Zero net flux estimates of septal extracellular glucose levels and the effects of glucose on septal extracellular GABA levels.

Authors:  Desiree L Krebs-Kraft; Gail Rauw; Glen B Baker; Marise B Parent
Journal:  Eur J Pharmacol       Date:  2009-04-01       Impact factor: 4.432

10.  Severe scene learning impairment, but intact recognition memory, after cholinergic depletion of inferotemporal cortex followed by fornix transection.

Authors:  Philip G F Browning; David Gaffan; Paula L Croxson; Mark G Baxter
Journal:  Cereb Cortex       Date:  2009-05-15       Impact factor: 5.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.